{"id":"W2559923310","doi":"10.1200/jco.2011.29.7_suppl.151","title":"A phase II study of sunitinib (SU) for maintenance therapy in metastatic castration-resistant prostate cancer (mCRPC) after response to docetaxel (D).","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Docetaxel; Clinical endpoint; Internal medicine; Adverse effect; Sunitinib; Chemotherapy; Phases of clinical research; Clinical trial; Oncology; Urology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002100565,0.001247035,0.002394025,0.0004973159,0.0004991964,0.0008590483,0.001002731,0.00131791,0.003168864],"category_scores_gemma":[0.0008039319,0.0006306701,0.001206956,0.0004556448,0.0007791623,0.0008051755,0.0002833128,0.00224204,0.0007718608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007681761,"about_ca_system_score_gemma":0.001653334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000903827,"about_ca_topic_score_gemma":0.00279092,"domain_scores_codex":[0.9995771,0.0001963015,0.00002699005,0.0000689886,0.0000387208,0.00009179598],"domain_scores_gemma":[0.99928,0.0001133899,0.0001311758,0.00006130493,0.0000392067,0.0003749922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7462044,0.07591352,0.009933051,0.001490871,0.001346391,0.0004206967,0.0004890133,0.001828854,0.05186155,0.0002165565,0.003501446,0.1067936],"study_design_scores_gemma":[0.4632207,0.5176579,0.01353274,0.00003150389,0.0003232552,0.0003092009,0.00004818387,0.0008060032,0.002587071,0.00007239674,0.001385182,0.00002575973],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945899,0.001796326,0.000336457,0.0002073468,0.00008073913,0.001833052,0.0004296974,0.00006732554,0.0006590887],"genre_scores_gemma":[0.9929873,0.001349889,0.0008938521,0.0003603459,0.000108526,0.001777032,0.001234925,0.00001868691,0.001269318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003168864,"threshold_uncertainty_score":0.01110899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3111972418231654,"score_gpt":0.5511332515752233,"score_spread":0.2399360097520579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}